Treat 4 Ramadan: A Randomised Control Trial Comparing Liraglutide vs. a Sulphonylurea as Add-On to Metformin in Patients With Established Type 2 Diabetes

被引：0
|
作者：
Davies, Melanie J.
Brady, Emer M.
Gray, Laura J.
Saeed, Mujahid
Wasim, Hanif
Khunti, Kamlesh
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2599-PO
引用
收藏
页码：A661 / A661
页数：1
相关论文
共 50 条
  • [21] The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
    Al Sifri, S.
    Basiounny, A.
    Echtay, A.
    Al Omari, M.
    Harman-Boehm, I.
    Kaddaha, G.
    Al Tayeb, K.
    Mahfouz, A. S.
    Al Elq, A.
    Radican, L.
    Oezesen, C.
    Katzeff, H. L.
    Musser, B. J.
    Suryawanshi, S.
    Girman, C. J.
    Davies, M. J.
    Engel, S. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (11) : 1132 - 1140
  • [22] COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN CHINA
    Gao, Lan
    Zhao, Fei-Li
    Li, Shu-Chuen
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (04) : 436 - 444
  • [23] COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Gao, L.
    Li, S. C.
    VALUE IN HEALTH, 2012, 15 (07) : A663 - A663
  • [24] Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin
    Hermansen, Kjeld
    Kolotkin, Ronette L.
    Hammer, Mette
    Zdravkovic, Milan
    Matthews, David
    PRIMARY CARE DIABETES, 2010, 4 (02) : 113 - 117
  • [25] Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea
    P. Khaloo
    S. Asadi Komeleh
    H. Alemi
    M. A. Mansournia
    A. Mohammadi
    A. Yadegar
    M. Afarideh
    S. Esteghamati
    M. Nakhjavani
    A. Esteghamati
    Journal of Endocrinological Investigation, 2019, 42 : 851 - 857
  • [26] Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea
    Khaloo, P.
    Komeleh, S. Asadi
    Alemi, H.
    Mansournia, M. A.
    Mohammadi, A.
    Yadegar, A.
    Afarideh, M.
    Esteghamati, S.
    Nakhjavani, M.
    Esteghamati, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (07) : 851 - 857
  • [27] COST-EFFECTIVENESS OF SITAGLIPTIN COMPARED TO SULPHONYLUREA AS AN ADD-ON TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Athanasakis, K.
    Zhuo, J.
    Chen, J.
    Boubouchairopoulou, N.
    Tarantilis, F.
    Papageorgiou, M.
    Retsa, P.
    Brandtmuller, A.
    Tunceli, K.
    Karokis, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2015, 18 (07) : A608 - A608
  • [28] Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes
    Al-Azzam, Sayer I.
    AlOmari, Mousa
    Khader, Yousef S.
    AlMahasneh, Fatimah A.
    Muflih, Suhaib M.
    Altawalbeh, Shoroq
    ENDOCRINE RESEARCH, 2012, 37 (01) : 7 - 11
  • [29] Liraglutide add-on to insulin degludec plus metformin vs addition of a single dose of insulin aspart to the largest meal in patients with Type 2 diabetes
    Russell-Jones, D.
    Mathieu, C.
    Rodbard, H. W.
    Cariou, B.
    Handelsman, Y.
    Philis-Tsimikas, A.
    Francisco, A. M. Ocampo
    Rana, A.
    Zinman, B.
    DIABETIC MEDICINE, 2014, 31 : 52 - 52
  • [30] Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy
    Ferrario, Maria Giovanna
    Lizan, Luis
    Montagnoli, Roberta
    Ramirez de Arellano, Antonio
    PRIMARY CARE DIABETES, 2016, 10 (03) : 220 - 226
12345